• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成功手术切除已知最大脾脏。

Successful Surgical Removal of the Largest Known Spleen.

作者信息

Hall David J, Dang Nam H, Shaw Christiana M

机构信息

Department of Surgery, University of Florida College of Medicine, USA.

Division of Hematology & Oncology, Department of Medicine, University of Florida College of Medicine, USA.

出版信息

Case Rep Surg. 2020 Feb 25;2020:6790808. doi: 10.1155/2020/6790808. eCollection 2020.

DOI:10.1155/2020/6790808
PMID:32158587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7061101/
Abstract

BACKGROUND

Splenic marginal zone lymphoma (SMZL) is a rare subtype of non-Hodgkin lymphoma that typically presents with symptomatic splenomegaly. The optimal treatment of SMZL not well established. A 44-year-old man with a history of low-grade B-cell lymphoproliferative disorder previously treated with chemotherapy presented with a three-month history of rapidly enlarging abdominal girth. He was found to have large symptomatic splenomegaly by computed tomography. After workup, he underwent preoperative angioembolization of the splenic artery followed by successful splenectomy. The spleen measured 45 cm in greatest dimension and weighed 12.14 kg, more than 12% of the patient's total body weight, making this both the largest spleen on record as well as the largest spleen ever surgically removed. Pathology was consistent with splenic marginal zone lymphoma. The patient did well and was discharged home on postoperative day 3.

CONCLUSIONS

SMZL is an infrequent condition that leads to progressive symptomatic splenomegaly which can be managed surgically providing symptomatic improvement and an overall satisfactory oncologic outcome. A multidisciplinary approach to complex cases of SMZL splenomegaly is imperative to achieving optimal outcomes.

摘要

背景

脾边缘区淋巴瘤(SMZL)是非霍奇金淋巴瘤的一种罕见亚型,通常表现为有症状的脾肿大。SMZL的最佳治疗方法尚未明确。一名44岁男性,有低度B细胞淋巴增殖性疾病病史,曾接受化疗,出现腹部周长迅速增大3个月的症状。计算机断层扫描发现他有巨大的有症状脾肿大。经过检查,他先接受了脾动脉术前血管栓塞,随后成功进行了脾切除术。脾脏最大径为45厘米,重12.14千克,超过患者总体重的12%,这使其成为有记录以来最大的脾脏,也是有史以来手术切除的最大脾脏。病理结果与脾边缘区淋巴瘤相符。患者情况良好,术后第3天出院。

结论

SMZL是一种罕见疾病,可导致进行性有症状脾肿大,手术治疗可改善症状并取得总体满意的肿瘤学结果。对于复杂的SMZL脾肿大病例,多学科方法对于实现最佳结果至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9a/7061101/d355c1a306ce/CRIS2020-6790808.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9a/7061101/cfd633071cda/CRIS2020-6790808.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9a/7061101/d355c1a306ce/CRIS2020-6790808.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9a/7061101/cfd633071cda/CRIS2020-6790808.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9a/7061101/d355c1a306ce/CRIS2020-6790808.002.jpg

相似文献

1
Successful Surgical Removal of the Largest Known Spleen.成功手术切除已知最大脾脏。
Case Rep Surg. 2020 Feb 25;2020:6790808. doi: 10.1155/2020/6790808. eCollection 2020.
2
Splenic marginal zone lymphoma: a case report and literature review.脾边缘区淋巴瘤:一例报告及文献复习
World J Surg Oncol. 2020 Oct 1;18(1):259. doi: 10.1186/s12957-020-02030-3.
3
Optimal Rituximab Monotherapy in Splenic Marginal Zone Lymphoma (SMZL): A Case Report and Brief Review.利妥昔单抗单药治疗脾边缘区淋巴瘤(SMZL)的优化方案:病例报告及简要综述
Recent Pat Anticancer Drug Discov. 2025;20(1):121-130. doi: 10.2174/0115748928247369231024112003.
4
Palliative splenic irradiation for symptomatic splenomegaly in non-Hodgkin lymphoma.非霍奇金淋巴瘤有症状脾肿大的姑息性脾照射
Ecancermedicalscience. 2018 Dec 13;12:887. doi: 10.3332/ecancer.2018.887. eCollection 2018.
5
[Splenic marginal zone lymphoma].[脾边缘区淋巴瘤]
Pan Afr Med J. 2017 Mar 1;26:111. doi: 10.11604/pamj.2017.26.111.11446. eCollection 2017.
6
Splenic marginal zone lymphoma treated with laparoscopic splenectomy: A case report.腹腔镜脾切除术治疗脾边缘区淋巴瘤:一例报告。
Int J Surg Case Rep. 2019;65:288-291. doi: 10.1016/j.ijscr.2019.11.008. Epub 2019 Nov 9.
7
Splenic marginal cell lymphoma (SMZL): report of its presentation with spontaneous rupture of the spleen.脾边缘区细胞淋巴瘤(SMZL):脾脏自发性破裂表现的报告。
J Surg Case Rep. 2013 Dec 16;2013(12):rjt105. doi: 10.1093/jscr/rjt105.
8
Concurrent Splenic Marginal Zone B Cell Lymphoma and Metastatic Pancreatic Adenocarcinoma Diagnosed on Splenectomy for Suspected Splenic Abscess.因疑似脾脓肿行脾切除术后诊断为并发脾边缘区B细胞淋巴瘤和转移性胰腺腺癌
Cureus. 2023 Feb 27;15(2):e35541. doi: 10.7759/cureus.35541. eCollection 2023 Feb.
9
Splenectomy in Lymphoproliferative Disorders: A Single Eastern European Center Experience.淋巴增生性疾病中的脾切除术:东欧单一中心经验
Medicina (Kaunas). 2019 Dec 27;56(1):12. doi: 10.3390/medicina56010012.
10
Massive splenomegaly due to B-cell lymphoma: A case report.B细胞淋巴瘤所致巨大脾肿大:一例报告。
Int J Surg Case Rep. 2018;48:76-78. doi: 10.1016/j.ijscr.2018.05.013. Epub 2018 May 29.

本文引用的文献

1
Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base.脾淋巴瘤的诊断性和治疗性脾切除术:美国国立癌症数据库分析
Hematology. 2019 Dec;24(1):378-386.
2
Palliative splenic irradiation for symptomatic splenomegaly in non-Hodgkin lymphoma.非霍奇金淋巴瘤有症状脾肿大的姑息性脾照射
Ecancermedicalscience. 2018 Dec 13;12:887. doi: 10.3332/ecancer.2018.887. eCollection 2018.
3
Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?利妥昔单抗在脾边缘区淋巴瘤的治疗中是否应取代脾切除术?
Best Pract Res Clin Haematol. 2018 Mar;31(1):65-72. doi: 10.1016/j.beha.2017.10.011. Epub 2017 Nov 7.
4
Splenic marginal zone lymphoma: from genetics to management.脾脏边缘区淋巴瘤:从遗传学角度到治疗管理。
Blood. 2016 Apr 28;127(17):2072-81. doi: 10.1182/blood-2015-11-624312. Epub 2016 Mar 17.
5
Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.对100例接受脾切除术作为一线治疗的脾边缘区淋巴瘤患者的长期随访分析。
Leuk Lymphoma. 2014 Aug;55(8):1854-60. doi: 10.3109/10428194.2013.861067. Epub 2014 May 6.
6
Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.利妥昔单抗单独或联合应用在脾边缘区淋巴瘤中优于其他治疗方式。
Br J Haematol. 2012 Nov;159(3):322-8. doi: 10.1111/bjh.12036. Epub 2012 Sep 27.
7
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases.基于血红蛋白浓度、血小板计数、乳酸脱氢酶水平和肝门外淋巴结病的脾脏边缘区淋巴瘤风险分层:593 例病例的开发和验证。
Br J Haematol. 2012 Oct;159(2):164-71. doi: 10.1111/bjh.12011. Epub 2012 Aug 24.
8
Radiotherapy of splenomegaly : a palliative treatment option for a benign phenomenon in malignant diseases.放射性脾区照射治疗:恶性疾病中良性现象的姑息性治疗选择。
Strahlenther Onkol. 2011 Apr;187(4):221-4. doi: 10.1007/s00066-011-2252-4. Epub 2011 Mar 7.
9
Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders.脾脏照射在慢性白血病和骨髓增殖性疾病中的临床指征及生物学机制
Radiother Oncol. 2001 Mar;58(3):235-46. doi: 10.1016/s0167-8140(00)00316-9.
10
Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders.
Am J Hosp Palliat Care. 1996 Nov-Dec;13(6):32-5. doi: 10.1177/104990919601300613.